Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 201 entries
Sorted by: Best Match Show Resources per page
Proceedings of the 5th European Symposium on Controlled Drug Delivery. Noordwijk aan Zee, The Netherlands, April 1-3, 1998.

Journal of controlled release : official journal of the Controlled Release Society

[No authors listed]
PMID: 10744452
J Control Release. 2000 Feb 14;64(1):1-347.

No abstract available.

Cite
Proceedings of the 5th European Symposium on Controlled Drug Delivery. Noordwijk aan Zee, The Netherlands, April 1-3, 1998. J Control Release. 2000;64(1):1-347
(2000). Proceedings of the 5th European Symposium on Controlled Drug Delivery. Noordwijk aan Zee, The Netherlands, April 1-3, 1998. Journal of controlled release : official journal of the Controlled Release Society, 64(1), 1-347.
"Proceedings of the 5th European Symposium on Controlled Drug Delivery. Noordwijk aan Zee, The Netherlands, April 1-3, 1998." Journal of controlled release : official journal of the Controlled Release Society vol. 64,1 (2000): 1-347.
Proceedings of the 5th European Symposium on Controlled Drug Delivery. Noordwijk aan Zee, The Netherlands, April 1-3, 1998. J Control Release. 2000 Feb 14;64(1):1-347. PMID: 10744452.
Copy Download .nbib Format: NLM
[New approach in drug designing: molecular-targeted drugs].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Tsuruo T.
PMID: 12655675
Nihon Naika Gakkai Zasshi. 2002 Dec 10;91(12):3401-7.

No abstract available.

Cite
Tsuruo T. [New approach in drug designing: molecular-targeted drugs]. Nihon Naika Gakkai Zasshi. 2002;91(12):3401-7
Tsuruo, T. (2002). [New approach in drug designing: molecular-targeted drugs]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 91(12), 3401-7.
Tsuruo, Takashi. "[New approach in drug designing: molecular-targeted drugs]." Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine vol. 91,12 (2002): 3401-7.
Tsuruo T. [New approach in drug designing: molecular-targeted drugs]. Nihon Naika Gakkai Zasshi. 2002 Dec 10;91(12):3401-7. Japanese. PMID: 12655675.
Copy Download .nbib Format: NLM
Advanced and controlled drug delivery systems in clinical disease management.

Pharmacy world & science : PWS

Brouwers JR.
PMID: 8933575
Pharm World Sci. 1996 Oct;18(5):153-62. doi: 10.1007/BF00820726.

Advanced and controlled drug delivery systems are important for clinical disease management. In this review the most important new systems which have reached clinical application are highlighted. Microbiologically controlled drug delivery is important for gastrointestinal diseases like ulcerative colitis...

Cite
Brouwers JR. Advanced and controlled drug delivery systems in clinical disease management. Pharm World Sci. 1996;18(5):153-62doi: 10.1007/BF00820726.
Brouwers, J. R. (1996). Advanced and controlled drug delivery systems in clinical disease management. Pharmacy world & science : PWS, 18(5), 153-62. https://doi.org/10.1007/BF00820726
Brouwers, J R. "Advanced and controlled drug delivery systems in clinical disease management." Pharmacy world & science : PWS vol. 18,5 (1996): 153-62. doi: https://doi.org/10.1007/BF00820726
Brouwers JR. Advanced and controlled drug delivery systems in clinical disease management. Pharm World Sci. 1996 Oct;18(5):153-62. doi: 10.1007/BF00820726. PMID: 8933575.
Copy Download .nbib Format: NLM
Literature alerts.

Drug delivery

[No authors listed]
PMID: 11232546
Drug Deliv. 2000 Oct-Dec;7(4):249-53. doi: 10.1080/107175400455191.

No abstract available.

Cite
Literature alerts. Drug Deliv. 2000;7(4):249-53doi: 10.1080/107175400455191.
(2000). Literature alerts. Drug delivery, 7(4), 249-53. https://doi.org/10.1080/107175400455191
"Literature alerts." Drug delivery vol. 7,4 (2000): 249-53. doi: https://doi.org/10.1080/107175400455191
Literature alerts. Drug Deliv. 2000 Oct-Dec;7(4):249-53. doi: 10.1080/107175400455191. PMID: 11232546.
Copy Download .nbib Format: NLM
State of pharmaceutics in 2002.

Pharmaceutical development and technology

Akers MJ.
PMID: 11852702
Pharm Dev Technol. 2002 Jan;7(1):v-vi.

No abstract available.

Cite
Akers MJ. State of pharmaceutics in 2002. Pharm Dev Technol. 2002;7(1):v-vi
Akers, M. J. (2002). State of pharmaceutics in 2002. Pharmaceutical development and technology, 7(1), v-vi.
Akers, Michael J. "State of pharmaceutics in 2002." Pharmaceutical development and technology vol. 7,1 (2002): v-vi.
Akers MJ. State of pharmaceutics in 2002. Pharm Dev Technol. 2002 Jan;7(1):v-vi. PMID: 11852702.
Copy Download .nbib Format: NLM
[Prospects of targeted therapies in oncology and problems of their molecular determinants: clinico-pathologic relationship].

Pathologica

Sobrero A.
PMID: 14989011
Pathologica. 2003 Oct;95(5):264.

No abstract available.

Cite
Sobrero A. Le prospettive delle targeted therapies in oncologia ed i problemi dei loro determinanti molecolari: rapporto clinico-patologo. [Prospects of targeted therapies in oncology and problems of their molecular determinants: clinico-pathologic relationship]. Pathologica. 2003;95(5):264
Sobrero, A. (2003). Le prospettive delle targeted therapies in oncologia ed i problemi dei loro determinanti molecolari: rapporto clinico-patologo. [Prospects of targeted therapies in oncology and problems of their molecular determinants: clinico-pathologic relationship]. Pathologica, 95(5), 264.
Sobrero, A. "Le prospettive delle targeted therapies in oncologia ed i problemi dei loro determinanti molecolari: rapporto clinico-patologo." [Prospects of targeted therapies in oncology and problems of their molecular determinants: clinico-pathologic relationship]. Pathologica vol. 95,5 (2003): 264.
Sobrero A. Le prospettive delle targeted therapies in oncologia ed i problemi dei loro determinanti molecolari: rapporto clinico-patologo. [Prospects of targeted therapies in oncology and problems of their molecular determinants: clinico-pathologic relationship]. Pathologica. 2003 Oct;95(5):264. Italian. PMID: 14989011.
Copy Download .nbib Format: NLM
[Intraocular drug delivery systems].

Archivos de la Sociedad Espanola de Oftalmologia

Rincón Alarcón A, Molina Martínez IT.
PMID: 16511709
Arch Soc Esp Oftalmol. 2006 Feb;81(2):57-9. doi: 10.4321/s0365-66912006000200002.

No abstract available.

Cite
Rincón Alarcón A, Molina Martínez IT. Sistemas de cesión controlada por vía intraocular. [Intraocular drug delivery systems]. Arch Soc Esp Oftalmol. 2006;81(2):57-9doi: 10.4321/s0365-66912006000200002.
Rincón Alarcón, A., & Molina Martínez, I. T. (2006). Sistemas de cesión controlada por vía intraocular. [Intraocular drug delivery systems]. Archivos de la Sociedad Espanola de Oftalmologia, 81(2), 57-9. https://doi.org/10.4321/s0365-66912006000200002
Rincón Alarcón, A, and Molina Martínez, I T. "Sistemas de cesión controlada por vía intraocular." [Intraocular drug delivery systems]. Archivos de la Sociedad Espanola de Oftalmologia vol. 81,2 (2006): 57-9. doi: https://doi.org/10.4321/s0365-66912006000200002
Rincón Alarcón A, Molina Martínez IT. Sistemas de cesión controlada por vía intraocular. [Intraocular drug delivery systems]. Arch Soc Esp Oftalmol. 2006 Feb;81(2):57-9. doi: 10.4321/s0365-66912006000200002. Spanish. PMID: 16511709.
Copy Download .nbib Format: NLM
Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.

International journal of cancer

Liu Y, Miyoshi H, Nakamura M.
PMID: 17390371
Int J Cancer. 2007 Jun 15;120(12):2527-37. doi: 10.1002/ijc.22709.

The diagnosis and treatment of cancer or tumor at the cellular level will be greatly improved with the development of techniques that enable the delivery of analyte probes and therapeutic agents into cells and cellular compartments. Organic and inorganic...

Cite
Liu Y, Miyoshi H, Nakamura M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer. 2007;120(12):2527-37doi: 10.1002/ijc.22709.
Liu, Y., Miyoshi, H., & Nakamura, M. (2007). Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. International journal of cancer, 120(12), 2527-37. https://doi.org/10.1002/ijc.22709
Liu, Yiyao, et al. "Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles." International journal of cancer vol. 120,12 (2007): 2527-37. doi: https://doi.org/10.1002/ijc.22709
Liu Y, Miyoshi H, Nakamura M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer. 2007 Jun 15;120(12):2527-37. doi: 10.1002/ijc.22709. PMID: 17390371.
Copy Download .nbib Format: NLM
Engineering strategies for drug delivery.

IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society

Wang Y.
PMID: 19150766
IEEE Eng Med Biol Mag. 2009 Jan-Feb;28(1):10-1. doi: 10.1109/MEMB.2008.931011.

No abstract available.

Cite
Wang Y. Engineering strategies for drug delivery. IEEE Eng Med Biol Mag. 2009;28(1):10-1doi: 10.1109/MEMB.2008.931011.
Wang, Y. (2009). Engineering strategies for drug delivery. IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society, 28(1), 10-1. https://doi.org/10.1109/MEMB.2008.931011
Wang, Yong. "Engineering strategies for drug delivery." IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society vol. 28,1 (2009): 10-1. doi: https://doi.org/10.1109/MEMB.2008.931011
Wang Y. Engineering strategies for drug delivery. IEEE Eng Med Biol Mag. 2009 Jan-Feb;28(1):10-1. doi: 10.1109/MEMB.2008.931011. PMID: 19150766.
Copy Download .nbib Format: NLM
PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine.

IDrugs : the investigational drugs journal

Bawa R.
PMID: 17642014
IDrugs. 2007 Jul;10(7):455-8.

No abstract available.

Cite
Bawa R. PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine. IDrugs. 2007;10(7):455-8
Bawa, R. (2007). PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine. IDrugs : the investigational drugs journal, 10(7), 455-8.
Bawa, Raj. "PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine." IDrugs : the investigational drugs journal vol. 10,7 (2007): 455-8.
Bawa R. PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine. IDrugs. 2007 Jul;10(7):455-8. PMID: 17642014.
Copy Download .nbib Format: NLM
Expanding role of nanotechnology in the management of colorectal cancer.

Expert review of anticancer therapy

Haq AI, Allen C, Grange P, Arya M.
PMID: 19192953
Expert Rev Anticancer Ther. 2009 Feb;9(2):157-9. doi: 10.1586/14737140.9.2.157.

No abstract available.

Cite
Haq AI, Allen C, Grange P, et al. Expanding role of nanotechnology in the management of colorectal cancer. Expert Rev Anticancer Ther. 2009;9(2):157-9doi: 10.1586/14737140.9.2.157.
Haq, A. I., Allen, C., Grange, P., & Arya, M. (2009). Expanding role of nanotechnology in the management of colorectal cancer. Expert review of anticancer therapy, 9(2), 157-9. https://doi.org/10.1586/14737140.9.2.157
Haq, Asif I, et al. "Expanding role of nanotechnology in the management of colorectal cancer." Expert review of anticancer therapy vol. 9,2 (2009): 157-9. doi: https://doi.org/10.1586/14737140.9.2.157
Haq AI, Allen C, Grange P, Arya M. Expanding role of nanotechnology in the management of colorectal cancer. Expert Rev Anticancer Ther. 2009 Feb;9(2):157-9. doi: 10.1586/14737140.9.2.157. PMID: 19192953.
Copy Download .nbib Format: NLM
New pharmacologic approaches to treating diabetic retinopathy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Ryan GJ.
PMID: 17720889
Am J Health Syst Pharm. 2007 Sep 01;64(17):S15-21. doi: 10.2146/ajhp070332.

PURPOSE: The goal of treatment of diabetic retinopathy, limitations of laser photocoagulation, endpoints used in clinical studies of diabetic retinopathy treatments, and the mechanism of action, efficacy, and safety of several new and emerging therapies targeting the biochemical pathways...

Cite
Ryan GJ. New pharmacologic approaches to treating diabetic retinopathy. Am J Health Syst Pharm. 2007;64(17):S15-21doi: 10.2146/ajhp070332.
Ryan, G. J. (2007). New pharmacologic approaches to treating diabetic retinopathy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 64(17), S15-21. https://doi.org/10.2146/ajhp070332
Ryan, Gina J. "New pharmacologic approaches to treating diabetic retinopathy." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists vol. 64,17 (2007): S15-21. doi: https://doi.org/10.2146/ajhp070332
Ryan GJ. New pharmacologic approaches to treating diabetic retinopathy. Am J Health Syst Pharm. 2007 Sep 01;64(17):S15-21. doi: 10.2146/ajhp070332. PMID: 17720889.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 201 entries